Categories
Anesthetic Vaporizer Recall: Draeger Removes Vapor 2000 and Vapor 3000 Vaporizers
Draeger is removing certain Vapor 2000 and Vapor 3000 Vaporizers due to impurities found within a component.
Categories
Early Alert: Broselow Rainbow Tape Issue from AirLife
AirLife is removing Broselow Rainbow Tapes due to incorrectly printed medication dosing information.
Categories
Anesthesia Kit Recall: Medline Removes Anesthesia Circuits and Anesthesia Circuit Kits
Medline is removing certain anesthesia circuit kits due to cracks and leaks in the tubing.
Categories
Olympus Expands Voluntary Recall for ViziShot 2 FLEX (19G) EBUS -TBNA Needles
CENTER VALLEY, Pa., (January 16, 2026) — Olympus Corporation has announced the expansion of a previous global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) after receiving and investigating complaints of device components ejecting or detaching during
Categories
Abbott Initiates Medical Device Correction for Certain FreeStyle Libre® 3 and FreeStyle Libre 3 Plus Sensors in the U.S.
ABBOTT PARK, Ill., Nov. 24, 2025 — Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some sensors may provide incorrect low glucose readings.
Categories
Early Alert: Dialysis Tubing Set Issue from Vantive
Prismaflex Set deaeration chambers may dislodge from the Prismaflex Control Unit during use.
Categories
FDA Approves First Treatment for Children With Menkes Disease
FDA Approves First Treatment for Children With Menkes Disease
http://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-menkes-disease
Categories
FDA Issues Guidance on Modernizing Statistical Methods for Clinical Trials
FDA Issues Guidance on Modernizing Statistical Methods for Clinical Trials
http://www.fda.gov/news-events/press-announcements/fda-issues-guidance-modernizing-statistical-methods-clinical-trials
Categories
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
http://www.fda.gov/news-events/press-announcements/fda-increases-flexibility-requirements-cell-and-gene-therapies-advance-innovation
Categories
Anthony Trinh, 123Herbals LLC (123HERBALS.COM) Issues Nationwide Recall of Silintan Capsules Due to the Presence of Undeclared Meloxicam
Rosemead, CA, ANTHONY TRINH, 123herbals LLC is voluntarily recalling all lots of Silintan capsules to the consumer level. FDA analysis has found the product to be tainted with meloxicam. Meloxicam, is an approved Nonsteroidal Anti-Inflammatory Drug, (NSAID) indicated for management of osteoarthritis
